Physician profile
Michael Miller
NPI 1235178559
$132,875.97
in general payments reported to CMS, 2019-2025
12 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $37K · 2021: $12K · 2022: $6,563 · 2023: $11K · 2024: $9,073 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Consulting Fee: $9,648 · Travel and Lodging: $2,840 · Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,480.00 |
| Consulting Fee | $9,647.50 |
| Travel and Lodging | $2,839.59 |
| Food and Beverage | $747.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $119,324.29 | 2019-2025 | Vascepa |
| Pfizer INC. | $8,760.00 | 2020-2023 | |
| Novo Nordisk INC | $2,747.50 | 2025 | |
| Seqirus USA INC | $1,800.00 | 2024 | |
| Abbott Laboratories | $98.34 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Stryker Corporation | $55.94 | 2024 | Ortholoc 2 Lapifuse |
| Ionis Pharmaceuticals, INC. | $47.31 | 2025 | Tryngolza |
| Misonix INC | $23.23 | 2021 | |
| Atricure, INC. | $19.36 | 2023 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.